18F-FDG PET/CT for Predicting Major Pathological Response to Neoadjuvant Therapy in Non-Small Cell Lung Cancer: A Meta-Analysis - Poll - MDSpire

18F-FDG PET/CT for Predicting Major Pathological Response to Neoadjuvant Therapy in Non-Small Cell Lung Cancer: A Meta-Analysis

  • By

  • Wu, Yaoyu

  • Hu, Boxiao

  • Liu, Dazhi

  • April 21, 2026

  • 0 min

Share

Original Source(s)

18F-FDG PET/CT for Predicting Major Pathological Response to Neoadjuvant Therapy in Non-Small Cell Lung Cancer: A Meta-Analysis

  • by Wu, Yaoyu , Hu, Boxiao , Liu, Dazhi

  • April 21, 2026

Related Content

Differentiation of hepatocellular carcinoma from hepatic hemangioma using diffusion-derived vessel density map-based radiomics features

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review